Abstract

Does Restricted Use of Repeat Doses of Surfactant after the Prophylactic Dose Increase the Risk of BPD or Death in Preterm Infants?

Highlights

  • Surfactant replacement therapy in the treatment of neonatal respiratory distress syndrome secondary to immaturity-related surfactant deficiency has been established as an effective and safe therapy since the early 1990s [1]

  • Restricting repeat doses of Survanta did not increase the risk of development of BPD or death in preterm infants with respiratory distress syndrome (RDS)

  • This contrasts with a rescue or treatment surfactant strategy, in which surfactant is given to preterm infants with a diagnosis of RDS based on signs and symptoms and chest radiographic findings consistent with RDS

Read more

Summary

Introduction

Surfactant replacement therapy in the treatment of neonatal respiratory distress syndrome secondary to immaturity-related surfactant deficiency has been established as an effective and safe therapy since the early 1990s [1]. Administration of beractant every 12 hours vs every 6 hours as recommended by the manufacturer found no difference in duration of mechanical ventilation and length of hospital stay [16] Based on this introduction it is evident that there is still significant debate regarding the need for the initial and subsequent surfactant treatment and the frequency of administration for improvement of associated morbidity and mortality due to neonatal RDS. We introduced a practice change in early 2008 whereby prophylactic surfactant administration was limited to infants

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.